1
|
Zhang L, Qiang J, Yang X, Wang D, Rehman AU, He X, Chen W, Sheng D, Zhou L, Jiang Y, Li T, Du Y, Feng J, Hu X, Zhang J, Hu X, Shao Z, Liu S. IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 Stability. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2020; 7:1901728. [PMID: 31921558 PMCID: PMC6947699 DOI: 10.1002/advs.201901728] [Citation(s) in RCA: 38] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Revised: 10/16/2019] [Indexed: 05/02/2023]
Abstract
Breast tumor initiating cells (BTICs) with ALDH+CD24-CD44+ phenotype are the most tumorigenic and invasive cell population in breast cancer. However, the molecular mechanisms are still unclear. Here, it is found that a negative immune regulator interleukin-1 receptor type 2 (IL1R2) is upregulated in breast cancer (BC) tissues and especially in BTICs. BC patients with high IL1R2 expression have a poorer overall survival and relapse-free survival. High IL1R2 promotes BTIC self-renewal and BC cell proliferation and invasion. Mechanistically, IL1R2 is activated by IL1β, as demonstrated by the fact that IL1β induces the release of IL1R2 intracellular domain (icd-IL1R2) and icd-IL1R2 then interacts with the deubiquitinase USP15 at the UBL2 domain and promotes its activity, which finally induces BMI1 deubiquitination at lysine 81 and stabilizes BMI1 protein. In addition, IL1R2 neutralizing antibody can suppress the protein expression of both IL1R2 and BMI1, and significantly abrogates the promoting effect of IL1R2 on BTIC self-renewal and BC cell growth both in vitro and in vivo. The current results indicate that blocking IL1R2 with neutralizing antibody provides a therapeutic approach to inhibit BC progression by targeting BTICs.
Collapse
Affiliation(s)
- Lixing Zhang
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- Department of OncologyDepartment of Breast SurgeryShanghai Medical CollegeFudan UniversityShanghai200032China
| | - Jiankun Qiang
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- Department of OncologyDepartment of Breast SurgeryShanghai Medical CollegeFudan UniversityShanghai200032China
| | - Xiaoli Yang
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- Department of OncologyDepartment of Breast SurgeryShanghai Medical CollegeFudan UniversityShanghai200032China
| | - Dong Wang
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- School of Life ScienceThe CAS Key Laboratory of Innate Immunity and Chronic DiseaseUniversity of Science and Technology of ChinaHefeiAnhui230027China
| | - Adeel ur Rehman
- School of Life ScienceThe CAS Key Laboratory of Innate Immunity and Chronic DiseaseUniversity of Science and Technology of ChinaHefeiAnhui230027China
| | - Xueyan He
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
| | - Weilong Chen
- School of Life ScienceThe CAS Key Laboratory of Innate Immunity and Chronic DiseaseUniversity of Science and Technology of ChinaHefeiAnhui230027China
| | - Dandan Sheng
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- School of Life ScienceThe CAS Key Laboratory of Innate Immunity and Chronic DiseaseUniversity of Science and Technology of ChinaHefeiAnhui230027China
| | - Lei Zhou
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- School of Life ScienceThe CAS Key Laboratory of Innate Immunity and Chronic DiseaseUniversity of Science and Technology of ChinaHefeiAnhui230027China
| | - Yi‐zhou Jiang
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
| | - Tao Li
- State Key Laboratory of ProteomicsInstitute of Basic Medical SciencesNational Center of Biomedical AnalysisBeijing100850China
| | - Ying Du
- Department of Laboratory Medicine and Central LaboratorySouthern Medical University Affiliated Fengxian HospitalShanghai201499China
| | - Jing Feng
- Department of Laboratory Medicine and Central LaboratorySouthern Medical University Affiliated Fengxian HospitalShanghai201499China
| | - Xin Hu
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- Department of OncologyDepartment of Breast SurgeryShanghai Medical CollegeFudan UniversityShanghai200032China
| | - Jian Zhang
- Department of Medical OncologyShanghai Medical CollegeFudan UniversityShanghai200032China
| | - Xi‐chun Hu
- Department of Medical OncologyShanghai Medical CollegeFudan UniversityShanghai200032China
| | - Zhi‐ming Shao
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- Department of OncologyDepartment of Breast SurgeryShanghai Medical CollegeFudan UniversityShanghai200032China
| | - Suling Liu
- Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesShanghai Medical CollegeKey Laboratory of Breast Cancer in ShanghaiInnovation Center for Cell Signaling NetworkCancer InstituteFudan UniversityShanghai200032China
- Department of OncologyDepartment of Breast SurgeryShanghai Medical CollegeFudan UniversityShanghai200032China
| |
Collapse
|
2
|
Lian Z, Lv FF, Yu J, Wang JW. The anti-inflammatory effect of microRNA-383-3p interacting with IL1R2 against homocysteine-induced endothelial injury in rat coronary arteries. J Cell Biochem 2018; 119:6684-6694. [PMID: 29693751 DOI: 10.1002/jcb.26854] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Accepted: 03/09/2018] [Indexed: 11/09/2022]
Abstract
MicroRNAs (miRs) are widely reported to be novel biomarkers involved in the process of coronary atherosclerosis (CAS). Hence, this study aims to explore the function of miR-383-3p targeting IL1R2 on inflammatory injury of coronary artery endothelial cells (CAECs) in CAS. The underlying regulatory mechanisms of miR-383-3p were analyzed in concert with the treatment of miR-383-3p mimics, miR-383-3p inhibitors, and the combination of miR-383-3p inhibitors and siRNA against IL1R2 in homocysteine (HCY)-induced CAECs. MTT, Hoechst 33258 staining, and tube formation assay were employed in order to measure cell viability, apoptosis, and tube formation, respectively. The levels of IL-1β, IL-6, IL-10, and IL-18 were determined by ELISA. IL1R2 was verified as the target gene of miR-383-3p by dual-luciferase reporter gene assay. MiR-383-3p was down-regulated in myocardial tissues of AS rats while IL1R2 was the reciprocal. The up-regulation of miR-383-3p decreased the levels of IL1R2, caspase-1, IL-1β, IL-6, and IL-18 expressions, as well as cell apoptosis rate in the HCY-induced CAECs, while IL-10 expression, cell viability, and tube formation ability were increased. These results were contraindicated in the HCY-induced CAECs treated by miR-383-3p inhibitors. In conclusion, miR-383-3p mediating IL1R2 prevents HCY-induced apoptosis and inflammation injury in CAECs through the inhibition of the activation of inflammasome signaling pathway. These findings highly indicate that miR-383-3p may be beneficial in the prevention of CAS and other cardiovascular diseases.
Collapse
Affiliation(s)
- Zheng Lian
- The First Department of Cardiovascular Medicine, Cangzhou Central Hospital, Cangzhou, Hebei Province, P. R. China
| | - Feng-Feng Lv
- The First Department of Cardiovascular Medicine, Cangzhou Central Hospital, Cangzhou, Hebei Province, P. R. China
| | - Jing Yu
- The First Department of Cardiovascular Medicine, Cangzhou Central Hospital, Cangzhou, Hebei Province, P. R. China
| | - Jia-Wang Wang
- The First Department of Cardiovascular Medicine, Cangzhou Central Hospital, Cangzhou, Hebei Province, P. R. China
| |
Collapse
|
3
|
Xia Y, Liu YQ, Chen K, Wang LC, Ma CY, Zhao YR. Association of IL-1R2 genetic polymorphisms with the susceptibility of ankylosing spondylitis in Northern Chinese Han population. Mod Rheumatol 2015; 25:908-12. [PMID: 25736356 DOI: 10.3109/14397595.2015.1024302] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- Yu Xia
- Department of Central Laboratory, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
| | - Yi-Qing Liu
- Department of Laboratory Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
| | - Kun Chen
- Department of Social Medicine and Health Services Administration, School of Public Health, Shandong University, Jinan, China
| | - Lai-Cheng Wang
- Department of Central Laboratory, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
| | - Chun-Yan Ma
- Department of Central Laboratory, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
| | - Yue-Ran Zhao
- Department of Central Laboratory, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
| |
Collapse
|
4
|
Osorio J, Trevisi E, Ballou M, Bertoni G, Drackley J, Loor J. Effect of the level of maternal energy intake prepartum on immunometabolic markers, polymorphonuclear leukocyte function, and neutrophil gene network expression in neonatal Holstein heifer calves. J Dairy Sci 2013; 96:3573-87. [DOI: 10.3168/jds.2012-5759] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2012] [Accepted: 02/22/2013] [Indexed: 11/19/2022]
|
5
|
D'Alessandro A, Zolla L, Scaloni A. The bovine milk proteome: cherishing, nourishing and fostering molecular complexity. An interactomics and functional overview. MOLECULAR BIOSYSTEMS 2010; 7:579-97. [PMID: 20877905 DOI: 10.1039/c0mb00027b] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Bovine milk represents an essential source of nutrients for lactating calves and a key raw material for human food preparations. A wealth of data are present in the literature dealing with massive proteomic analyses of milk fractions and independent targeted studies on specific groups of proteins, such as caseins, globulins, hormones and cytokines. In this study, we merged data from previous investigations to compile an exhaustive list of 573 non-redundant annotated protein entries. This inventory was exploited for integrated in silico studies, including functional GO term enrichment (FatiGO/Babelomics), multiple pathway and network analyses. As expected, most of the milk proteins were grouped under pathways/networks/ontologies referring to nutrient transport, lipid metabolism and objectification of the immune system response. Notably enough, another functional family was observed as the most statistically significant one, which included proteins involved in the induction of cellular proliferation processes as well as in anatomical and haematological system development. Although the latter function for bovine milk proteins has long been postulated, studies reported so far mainly focused on a handful of molecules and missed the whole overview resulting from an integrated holistic analysis. A preliminary map of the bovine milk proteins interactome was also built up, which will be refined in future as result of the widespread use of quantitative methods in protein interaction studies and consequent reduction of false-positives within associated databases.
Collapse
Affiliation(s)
- Angelo D'Alessandro
- Department of Environmental Sciences, University of Tuscia, Largo dell'Università, SNC, 01100 Viterbo, Italy
| | | | | |
Collapse
|
6
|
Choi HS, Ko YG, Lee JS, Kwon OY, Kim SK, Cheong C, Jang KH, Kang SA. Neuroprotective effects of consuming bovine colostrum after focal brain ischemia/reperfusion injury in rat model. Nutr Res Pract 2010; 4:196-202. [PMID: 20607064 PMCID: PMC2895699 DOI: 10.4162/nrp.2010.4.3.196] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2010] [Revised: 04/29/2010] [Accepted: 05/12/2010] [Indexed: 02/03/2023] Open
Abstract
To investigate the neuroprotective effects of bovine colostrums (BC), we evaluate the ability of consuming BC after focal brain ischemia/reperfusion injury rat model to reduce serum cytokine levels and infarct volume, and improve neurological outcome. Sprague-Dawley rats were randomly divided into 4 groups; one sham operation and three experimental groups. In the experimental groups, MCA occlusion (2 h) and subsequent reperfusion (O/R) were induced with regional cerebral blood flow monitoring. One hour after MCAO/R and once daily during the experiment, the experimental group received BC while the other groups received 0.9% saline or low fat milk (LFM) orally. Seven days later, serum pro-inflammatory cytokine (IL-1β, IL-6, and TNF-α) and anti-inflammatory cytokine (IL-10) levels were assessed. Also, the infarct volume was assessed by using a computerized image analysis system. Behavioral function was also assessed using a modified neurologic severity score and corner turn test during the experiment. Rats receiving BC after focal brain I/R showed a significant reduction (-26%/-22%) in infarct volume compared to LFM/saline rats, respectively (P < 0.05). Serum IL-1β, IL-6, and TNF-α levels were decreased significantly in rats receiving BC compared to LFM/saline rats (P < 0.05). In behavioral tests, daily BC intake showed consistent and significant improvement of neurological deficits for 7 days after MCAO/R. BC ingestion after focal brain ischemia/reperfusion injury may prevent brain injury by reducing serum pro-inflammatory cytokine levels and brain infarct volume in a rat model.
Collapse
Affiliation(s)
- Han Sung Choi
- Department of Emergency Medicine, College of Medicine, Kyung Hee University, Seoul 130-702, Korea
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Sabbagh F, Lecerf F, Maurois P, Bac P, German-Fattal M. Allogeneic activation is attenuated in a model of mouse lung perfused with magnesium-deficient blood. Transpl Immunol 2006; 16:200-7. [PMID: 17138054 DOI: 10.1016/j.trim.2006.09.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2006] [Revised: 08/03/2006] [Accepted: 09/07/2006] [Indexed: 01/11/2023]
Abstract
Hypomagnesemia, which is frequently observed in patients treated with calcineurin inhibitors to prevent rejection after allogeneic transplantation, has been associated with a faster rate of decline in allograft function. The effect of hypomagnesemia on lung allograft has not been reported yet. In our model of isolated mouse lung, we have evaluated the early effects of allogeneic lung perfusion with blood from magnesium (Mg)-deficient mice for 3 h on lung activation and remodelling, compared to isogeneic perfusion. Hypomagnesemia (0.21+/-0.07 mmol Mg(2+)/l) was observed in blood from Mg-deficient mice, but no inflammatory pattern. The mRNA level of the intercellular adhesion molecule (ICAM)-1, but neither of the vascular cell adhesion molecule (VCAM)-1, nor of the cytokines tumor necrosis factor (TNF)alpha and interleukin (IL)-2, was enhanced (p<0.05). Although caspase-3 mRNA was transiently enhanced, no apoptotic cells were evidenced in lung tissues even after 3 h. Using cDNA array, we found that the genes encoding RANKL, RANK, TNFR2, NFATX, IL-1R2, IL-6R gp130, SOCS3, PDGFRB, P63, CSF3R, CXCL1, CXCL5, CX3CL1, CSF1, which are involved in inflammation and apoptosis regulation, were markedly up-regulated in allogeneic conditions. Our results support a limited allogeneic activation and an early stage of the inflammatory process in lung, at the time of inflammatory cell recruitment without lung tissue remodelling, as a result of hypomagnesemia. These findings suggest that cyclosporine-related hypomagnesemia, observed in most of the transplanted patients, does not constitute an additional risk for lung allograft outcome.
Collapse
Affiliation(s)
- Fadi Sabbagh
- CNRS UMR 8162, IFR 13, Université Paris-Sud 11, Centre Chirurgical Marie-Lannelongue, 133 avenue de la Résistance, 92350 Le Plessis Robinson, France
| | | | | | | | | |
Collapse
|